308 related articles for article (PubMed ID: 32295992)
1. NEK7: a potential therapy target for NLRP3-related diseases.
Liu G; Chen X; Wang Q; Yuan L
Biosci Trends; 2020 May; 14(2):74-82. PubMed ID: 32295992
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
3. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.
Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B
EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
Kim SK; Choe JY; Park KY
Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
[TBL] [Abstract][Full Text] [Related]
5. NEK7-Mediated Activation of NLRP3 Inflammasome Is Coordinated by Potassium Efflux/Syk/JNK Signaling During
Liu R; Liu Y; Liu C; Gao A; Wang L; Tang H; Wu Q; Wang X; Tian D; Qi Z; Shen Y
Front Immunol; 2021; 12():747370. PubMed ID: 34603335
[No Abstract] [Full Text] [Related]
6. NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.
Liu H; Gu C; Liu M; Liu G; Wang Y
Biochem Pharmacol; 2020 Jul; 177():113998. PubMed ID: 32353421
[TBL] [Abstract][Full Text] [Related]
7. NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury.
Ji X; Song Z; He J; Guo S; Chen Y; Wang H; Zhang J; Xu X; Liu J
Exp Cell Res; 2021 Jan; 398(2):112418. PubMed ID: 33309808
[TBL] [Abstract][Full Text] [Related]
8. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
He Y; Zeng MY; Yang D; Motro B; Núñez G
Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970
[TBL] [Abstract][Full Text] [Related]
9. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.
Chen X; Liu G; Yuan Y; Wu G; Wang S; Yuan L
Cell Death Dis; 2019 Dec; 10(12):906. PubMed ID: 31787755
[TBL] [Abstract][Full Text] [Related]
10. PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature.
Liu L; Jiang Y; Steinle JJ
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):14. PubMed ID: 35006270
[TBL] [Abstract][Full Text] [Related]
11. NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases.
Xu J; Lu L; Li L
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):966-968. PubMed ID: 27563009
[No Abstract] [Full Text] [Related]
12. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation.
Li M; Zhang Y; Qiu S; Zhuang W; Jiang W; Wang C; Zhang S; Zhou Z; Sun T; Ke Z; Guo W; Qiao Y; Shi X
Int Immunopharmacol; 2021 Jun; 95():107576. PubMed ID: 33770730
[TBL] [Abstract][Full Text] [Related]
13. Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation.
Hughes MM; Hooftman A; Angiari S; Tummala P; Zaslona Z; Runtsch MC; McGettrick AF; Sutton CE; Diskin C; Rooke M; Takahashi S; Sundararaj S; Casarotto MG; Dahlstrom JE; Palsson-McDermott EM; Corr SC; Mills KHG; Preston RJS; Neamati N; Xie Y; Baell JB; Board PG; O'Neill LAJ
Cell Rep; 2019 Oct; 29(1):151-161.e5. PubMed ID: 31577945
[TBL] [Abstract][Full Text] [Related]
14. ALK-JNK signaling promotes NLRP3 inflammasome activation and pyroptosis via NEK7 during Streptococcus pneumoniae infection.
Wang X; Zhao Y; Wang D; Liu C; Qi Z; Tang H; Liu Y; Zhang S; Cui Y; Li Y; Liu R; Shen Y
Mol Immunol; 2023 May; 157():78-90. PubMed ID: 37001294
[TBL] [Abstract][Full Text] [Related]
15. 1,25(OH)
Cao R; Ma Y; Li S; Shen D; Yang S; Wang X; Cao Y; Wang Z; Wei Y; Li S; Liu G; Zhang H; Wang Y; Ma Y
J Leukoc Biol; 2020 Jul; 108(1):283-295. PubMed ID: 32237257
[TBL] [Abstract][Full Text] [Related]
16. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.
Sharif H; Wang L; Wang WL; Magupalli VG; Andreeva L; Qiao Q; Hauenstein AV; Wu Z; Núñez G; Mao Y; Wu H
Nature; 2019 Jun; 570(7761):338-343. PubMed ID: 31189953
[TBL] [Abstract][Full Text] [Related]
17. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.
Schmid-Burgk JL; Chauhan D; Schmidt T; Ebert TS; Reinhardt J; Endl E; Hornung V
J Biol Chem; 2016 Jan; 291(1):103-9. PubMed ID: 26553871
[TBL] [Abstract][Full Text] [Related]
18. Mst1/2-ALK promotes NLRP3 inflammasome activation and cell apoptosis during Listeria monocytogenes infection.
Gao A; Tang H; Zhang Q; Liu R; Wang L; Liu Y; Qi Z; Shen Y
J Microbiol; 2021 Jul; 59(7):681-692. PubMed ID: 33877580
[TBL] [Abstract][Full Text] [Related]
19. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7.
Jin X; Liu D; Zhou X; Luo X; Huang Q; Huang Y
Cell Rep Med; 2023 Dec; 4(12):101310. PubMed ID: 38118409
[TBL] [Abstract][Full Text] [Related]
20. NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases.
Wang J; Chen S; Liu M; Zhang M; Jia X
Inflammopharmacology; 2022 Aug; 30(4):1179-1187. PubMed ID: 35829941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
